Oxford Medical Products’ Post

An insightful panel discussion - well worth watching to hear how different regulatory, patient group and pharma stakeholders incorporate the patient perspective to help ensure approved therapies are fit for purpose

📢 Exciting News! Alpha Clinical Development is now on X! 🎉 Follow us here to stay updated on our latest insights in pharmacovigilance, clinical protocol services, and safety adjudication. Let's connect and drive innovation together! #ACD #Pharmacovigilance #ClinicalResearch #SafetyAdjudication #HealthcareInnovation #FollowUsOnX

The olympic torch is headed to SoCal, and so are WE! 🤗 Please join myself & the entire planning committee in Palm Springs, California, USA next April 2025 for a full week of industry greatness. It's the PDA - Parenteral Drug Association's flagship event of the year and 2025 is shaping up to be exceptional. We are now accepting abstracts to become a presenter, and there are 3 ways you can do so: podium, lighting talks, or a poster. Deadline for submission is 29 September 2024, which is not so far from now. We already have received abstracts - how exciting that? Link in comments for where to submit. DM me if you need anything. #PDAWeek2025 #AsepticProcessing #ContaminationControl

Thrilled to have attended the SCRMP Clinical Research Symposium 2024 organised by SCRMP (Pharmacy Wing) - Student Forum on 31st August and 1st September! Grateful for the insightful sessions and the opportunity to learn from leaders in the field. Special thanks to Mohammad Gayoor Khan and Morziul Haque for his invaluable guidance and support throughout. Proud to have received my certificate of participation and excited to apply this knowledge in future endeavors! #SCRMP2024 #ClinicalResearch #ContinuousLearning"

If you were able to attend, you would have found out the true and authentic meaning of the word #Novel, as it pertains to a device/idea/solution etc in #Startups generally, but, in my opinion #MedTech, specifically.

excellent overview of a truly dynamic field. It's great being part of it.

Life sciences organizations face unique challenges with ASC 606. Explore how to assess collaborative arrangements and account for variable consideration with EisnerAmper’s latest article. https://okt.to/U6RJuf #ASC606 #LifeSciences #RevenueRecognition #FinancialReporting

We are back with 'Lessons from the SV95C qualification Series'. In 2023, Sysnav and its partners qualified SV95C, the first digital primary endpoint to the European Medicines Agency (EMA). In the next few months, we'll share our biggest takeaways from the qualification. 🤝 Lesson 2: It takes a village Creating meaningful endpoints requires interaction between physicians, engineers, patient associations, and regulators.  Digital endpoints should be: 👉 Meaningful for patients 👉 Used by clinicians 👉 Trusted by regulators The SV95C EMA qualification is the result of collaboration with University of Oxford, Roche, Parent Project Muscular Dystrophy, Muscular Dystrophy UK, World Duchenne Organization, and many others.

Informative summary in growing field of radiopharmaceuticals.

Five key FDA decisions to watch for and more in this week’s life sciences recap.